China National Biotechnology Group (CNPG) said today, Sunday, “The results of human tests for one of possible vaccines to prevent emerging corona virus indicate that it may be safe and effective, and it is second possible vaccine from company that produces encouraging results.” In clinical trials. “
According to preliminary data, experimental vaccine, developed by a Beijingbased unit, stimulated highlevel production of antibodies in all participants who received it in first stage of a twostage clinical trial that included 1120 healthy subjects. However, company did not disclose specific observations.
Authorities have allowed Chinese companies and research centers to test 8 potential human vaccines in China and abroad, putting China ahead of race to develop a vaccine to prevent disease that has killed nearly half a million people worldwide so far.
The company, which is affiliated with state pharmaceutical group Cinopharm, said this month that anor possible vaccine produced by its unit in Wuhan also stimulated production of high levels of antibodies safely in participants in clinical trials, also based on preliminary results.
Any vaccine needs to be proven effective in a third stage of testing in humans, involving thousands of participants, before it can be allowed to go on sale.